Co - formulation of antibodies

搜索文档
Spyre Therapeutics (NasdaqGS:SYRE) Conference Transcript
2025-09-15 23:02
Spyre Therapeutics (NasdaqGS:SYRE) Conference September 15, 2025 10:00 AM ET Company ParticipantsCameron Turtle - CEOSheldon Sloan - CMONoneHey, great. We're back, everyone. Happy to have Spyre Therapeutics CEO Cameron Turtle and CMO Sheldon Sloan with us now. Maybe I'll kick it over to Cameron to kick things off with a quick overview of Spyre, and then we'll get into a Q&A. Cameron, over to you.Cameron TurtleYeah, thanks so much for having us this morning, Alex. Maybe just to kick things off, Spyre is aimi ...